STAT17h
FDA commissioner: We need action and higher-quality research on ultra-processed foods
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
RFK Jr. vow to purge FDA sets up collision with Big Pharma
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
FiercePharma2d
After election, FDA's Califf lays out hopes for his Trump-appointed successor
While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out ...
FDA employees consider how to handle RFK Jr., including leaving
Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...
In RFK Jr., drugmakers face an antagonist with regulatory power
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...
MassDevice9h
Trump taps RFK Jr. to run HHS — but two groups could block him
Kennedy has a history of vaccine disinformation and suggested a ban on fluoride in water and eliminating entire FDA ...
“Pack your bags” RFK Jr. tells FDA. His war on public health under Trump would only accelerate
In an interview with NPR on Wednesday, Kennedy said Trump had already assigned him three tasks: to reduce the “corruption and ...
Robert Kennedy Poised To Lead Health And Human Services: Why FDA, NIH Officials Are Nervous
FDA employees are reportedly eyeing exits amid talks of Robert F. Kennedy Jr. joining Trump's administration. Concerns extend ...
Who Decides Who Leads U.S. Health Agencies?
The Secretary is appointed by the president and must be confirmed by the Senate, which is currently ruled by a Republican ...
STAT2d
BioNTech acquires its Chinese cancer drug partner
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...